Navigation Links
LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
Date:4/18/2008

BURLINGTON, Mass., April 18 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it will release its 2008 first quarter financial results on April 30, 2008, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The call will be broadcast simultaneously over the internet.

Interested participants may listen to the live webcast at http://www.lemaitre.com/investor, or dial in at 866-831-6247 (+1 617-213-8856 for international callers), using passcode 22576785. A replay of the call will be available at http://www.lemaitre.com/investor .

During the call, LeMaitre's senior management will provide an overview of the first quarter results, business highlights and company outlook.

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com .


'/>"/>
SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. LeMaitre Vascular Announces Changes to Its Executive Management Team
2. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
3. LeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
4. LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
5. LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference
6. LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19% Increase
7. LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
8. LeMaitre Vascular to Start Italian Sales Force
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
10. MSA Schedules First Quarter Earnings Webcast
11. Omnicell Schedules First Quarter 2008 Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: